HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke

Achilleas Papagiannis1, Christina Gkolfinopoulou2, Konstantinos Tziomalos1

  • 1First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.

Insights

High-density lipoprotein (HDL) function and composition, not just concentration, are linked to ischemic stroke severity and outcomes. Impaired cholesterol efflux capacity and altered HDL composition predict worse stroke outcomes and mortality.

Area of Science:

  • Cardiovascular Research
  • Neuroscience
  • Biochemistry

Background:

  • High-density lipoprotein (HDL) concentration is a poor indicator of cardiovascular risk.
  • HDL function and composition are more strongly associated with cardiovascular morbidity.
  • The predictive value of HDL function and composition for ischemic stroke severity and outcome remains unclear.

Purpose of the Study:

  • To investigate the association between HDL function and composition with ischemic stroke severity.
  • To evaluate the predictive value of HDL function and composition for stroke outcome.
  • To identify potential biomarkers for risk stratification in acute ischemic stroke patients.

Main Methods:

  • Prospective study of 199 acute ischemic stroke patients.
  • Stroke severity assessed using the National Institutes of Health Stroke Scale (NIHSS).
  • HDL cholesterol efflux capacity (CEC), phospholipid levels, LCAT-phospholipase activity, PON1-arylesterase activity, and SAA1 content were measured.

Main Results:

  • Severe stroke patients exhibited lower HDL CEC, phospholipid levels, and LCAT activity, with higher SAA1 content.
  • Poorer outcomes (dependency, mortality) were associated with reduced HDL CEC, PON1 activity, phospholipid, and LCAT activity, and increased HDL SAA1.
  • HDL CEC and HDL-associated PON1 activity independently predicted dependency at discharge.

Conclusions:

  • Alterations in HDL cholesterol efflux capacity and composition are linked to ischemic stroke severity and patient outcomes.
  • These HDL characteristics may serve as valuable biomarkers for risk stratification.
  • Findings suggest potential for improved management strategies in acute ischemic stroke based on HDL profiles.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
217
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
32
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
743